vs

Side-by-side financial comparison of DBV Technologies S.A. (DBVT) and Beyond Air, Inc. (XAIR). Click either name above to swap in a different company.

DBV Technologies S.A. is the larger business by last-quarter revenue ($2.8M vs $2.2M, roughly 1.3× Beyond Air, Inc.). Beyond Air, Inc. runs the higher net margin — -334.4% vs -1195.5%, a 861.2% gap on every dollar of revenue. On growth, DBV Technologies S.A. posted the faster year-over-year revenue change (158.8% vs 104.7%). Beyond Air, Inc. produced more free cash flow last quarter ($-4.3M vs $-32.6M). Over the past eight quarters, Beyond Air, Inc.'s revenue compounded faster (116.1% CAGR vs 12.4%).

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

Delta Air Lines, Inc. is a major airline in the United States headquartered in Atlanta, Georgia, operating nine hubs, with Hartsfield–Jackson Atlanta International Airport being its largest in terms of total passengers and number of departures. With its regional subsidiaries and contractors operating under the brand name Delta Connection, Delta has over 5,400 flights daily and serves 325 destinations in 52 countries on six continents.

DBVT vs XAIR — Head-to-Head

Bigger by revenue
DBVT
DBVT
1.3× larger
DBVT
$2.8M
$2.2M
XAIR
Growing faster (revenue YoY)
DBVT
DBVT
+54.1% gap
DBVT
158.8%
104.7%
XAIR
Higher net margin
XAIR
XAIR
861.2% more per $
XAIR
-334.4%
-1195.5%
DBVT
More free cash flow
XAIR
XAIR
$28.3M more FCF
XAIR
$-4.3M
$-32.6M
DBVT
Faster 2-yr revenue CAGR
XAIR
XAIR
Annualised
XAIR
116.1%
12.4%
DBVT

Income Statement — Q3 FY2025 vs Q3 FY2026

Metric
DBVT
DBVT
XAIR
XAIR
Revenue
$2.8M
$2.2M
Net Profit
$-33.2M
$-7.3M
Gross Margin
13.7%
Operating Margin
-1235.7%
-300.6%
Net Margin
-1195.5%
-334.4%
Revenue YoY
158.8%
104.7%
Net Profit YoY
-8.9%
43.7%
EPS (diluted)
$-0.24
$-0.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBVT
DBVT
XAIR
XAIR
Q4 25
$2.2M
Q3 25
$2.8M
$1.8M
Q2 25
$1.5M
$1.8M
Q1 25
$1.2M
Q4 24
$1.1M
Q3 24
$798.0K
Q2 24
$1.2M
$683.0K
Q1 24
$1.4M
$470.0K
Net Profit
DBVT
DBVT
XAIR
XAIR
Q4 25
$-7.3M
Q3 25
$-33.2M
$-7.9M
Q2 25
$-41.9M
$-7.7M
Q1 25
$-8.0M
Q4 24
$-13.0M
Q3 24
$-13.4M
Q2 24
$-33.1M
$-12.2M
Q1 24
$-27.3M
$-13.7M
Gross Margin
DBVT
DBVT
XAIR
XAIR
Q4 25
13.7%
Q3 25
-16.4%
Q2 25
8.9%
Q1 25
-2.8%
Q4 24
-20.1%
Q3 24
-135.8%
Q2 24
-48.6%
Q1 24
-109.4%
Operating Margin
DBVT
DBVT
XAIR
XAIR
Q4 25
-300.6%
Q3 25
-1235.7%
-421.4%
Q2 25
-2806.2%
-432.8%
Q1 25
-622.6%
Q4 24
-1021.6%
Q3 24
-1608.1%
Q2 24
-2914.9%
-1988.3%
Q1 24
-2029.7%
-2687.9%
Net Margin
DBVT
DBVT
XAIR
XAIR
Q4 25
-334.4%
Q3 25
-1195.5%
-436.7%
Q2 25
-2858.4%
-437.0%
Q1 25
-697.4%
Q4 24
-1215.7%
Q3 24
-1673.9%
Q2 24
-2852.4%
-1786.4%
Q1 24
-1943.5%
-2916.4%
EPS (diluted)
DBVT
DBVT
XAIR
XAIR
Q4 25
$-0.85
Q3 25
$-0.24
$-1.25
Q2 25
$-0.31
$-1.53
Q1 25
$13.26
Q4 24
$-2.96
Q3 24
$-5.67
Q2 24
$-0.34
$-5.32
Q1 24
$-0.28
$-0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBVT
DBVT
XAIR
XAIR
Cash + ST InvestmentsLiquidity on hand
$69.8M
$11.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$52.9M
$8.1M
Total Assets
$110.5M
$36.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBVT
DBVT
XAIR
XAIR
Q4 25
$11.7M
Q3 25
$69.8M
$10.7M
Q2 25
$103.2M
$6.5M
Q1 25
$6.9M
Q4 24
$10.9M
Q3 24
$28.4M
Q2 24
$66.2M
$21.4M
Q1 24
$101.5M
$34.5M
Total Debt
DBVT
DBVT
XAIR
XAIR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$11.8M
Q3 24
$12.5M
Q2 24
$17.5M
Q1 24
$17.5M
Stockholders' Equity
DBVT
DBVT
XAIR
XAIR
Q4 25
$8.1M
Q3 25
$52.9M
$12.7M
Q2 25
$86.2M
$9.9M
Q1 25
$13.6M
Q4 24
$17.6M
Q3 24
$28.1M
Q2 24
$79.1M
$16.1M
Q1 24
$111.7M
$25.0M
Total Assets
DBVT
DBVT
XAIR
XAIR
Q4 25
$36.8M
Q3 25
$110.5M
$31.0M
Q2 25
$143.4M
$28.1M
Q1 25
$30.1M
Q4 24
$34.1M
Q3 24
$53.0M
Q2 24
$114.2M
$46.5M
Q1 24
$145.9M
$57.0M
Debt / Equity
DBVT
DBVT
XAIR
XAIR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.67×
Q3 24
0.44×
Q2 24
1.08×
Q1 24
0.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBVT
DBVT
XAIR
XAIR
Operating Cash FlowLast quarter
$-32.4M
$-4.2M
Free Cash FlowOCF − Capex
$-32.6M
$-4.3M
FCF MarginFCF / Revenue
-1173.5%
-193.8%
Capex IntensityCapex / Revenue
4.2%
1.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-138.3M
$-22.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBVT
DBVT
XAIR
XAIR
Q4 25
$-4.2M
Q3 25
$-32.4M
$-4.5M
Q2 25
$-33.9M
$-4.5M
Q1 25
$-7.0M
Q4 24
$-7.7M
Q3 24
$-13.3M
Q2 24
$-35.1M
$-10.2M
Q1 24
$-34.7M
$-10.7M
Free Cash Flow
DBVT
DBVT
XAIR
XAIR
Q4 25
$-4.3M
Q3 25
$-32.6M
$-4.7M
Q2 25
$-33.9M
$-4.7M
Q1 25
$-8.5M
Q4 24
$-8.3M
Q3 24
$-14.5M
Q2 24
$-35.8M
$-12.9M
Q1 24
$-36.0M
$-12.7M
FCF Margin
DBVT
DBVT
XAIR
XAIR
Q4 25
-193.8%
Q3 25
-1173.5%
-258.5%
Q2 25
-2316.5%
-268.4%
Q1 25
-733.9%
Q4 24
-771.5%
Q3 24
-1819.9%
Q2 24
-3084.0%
-1881.8%
Q1 24
-2560.6%
-2692.8%
Capex Intensity
DBVT
DBVT
XAIR
XAIR
Q4 25
1.5%
Q3 25
4.2%
13.5%
Q2 25
2.2%
11.3%
Q1 25
130.0%
Q4 24
50.1%
Q3 24
147.2%
Q2 24
63.0%
391.4%
Q1 24
94.9%
410.9%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons